In a statement to LADbible, a spokesperson for Eli Lilly said the following: "Retatrutide is an investigational, once-weekly, triple hormone receptor agonist, which activates the body's receptors for glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon
It does not suggest stretching a vial beyond its stated window, and repeats that compounded product still requires pharmacy and provider involvement
Sci Rep (2020) 10(1):28233
At Drip Lounge, we source exclusively from FDA-registered outsourcing facilities and PCAB-accredited compounding pharmacies the highest available tier for compounded sterile preparations
This approach prevents accidental double-dosing and maintains your weekly or monthly rhythm
Understanding potential side effects helps you know what to look for and when to reach out for medical help